ArticleScientific reports2023

Folate receptor targeted nanoparticles containing niraparib and doxorubicin as a potential candidate for the treatment of high grade serous ovarian cancer.

Lucy Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.